The moment medical technology leads to something very human: patients smile again.
This is the moment we work for.
Video player failed to load.
The New Humphrey Field Analyzer 3 from ZEISS Sets a New Standard for Efficient Visual Field Testing
Carl Zeiss Meditec invests in innovative radiotherapy solution for wet age-related macular degeneration developed by Oraya Therapeutics, Inc.
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organization. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.